Biomarkers of Nicotine Exposure: Forensic Toxicological Significance, Analytical Methods, and Interpretative Challenges

Nicotine exposure may arise from combustible tobacco, smokeless tobacco, electronic nicotine delivery systems, heated tobacco products, nicotine replacement medicines, occupational contact, environmental contamination, or accidental and intentional ingestion. A forensic measurement must therefore address a specific question rather than simply establish whether a nicotine-related compound is present. This narrative review examines nicotine pharmacokinetics, major biomarkers, biological specimens, analytical methods, and the evidentiary boundaries of interpretation. Parent nicotine is most informative about relatively recent exposure but is rapidly redistributed and eliminated. Cotinine offers a longer detection interval, whereas trans-3′-hydroxycotinine and the nicotine metabolite ratio inform metabolic activity. Urinary total nicotine equivalents can characterise nicotine intake more comprehensively in research settings. The tobacco-specific nitrosamine metabolite NNAL provides evidence of exposure to the tobacco-derived precursor NNK over a comparatively prolonged period, although it does not measure nicotine dose or establish a precise exposure date. Blood, urine, saliva, hair, and nails differ in sampling practicality, analyte concentration, temporal resolution, and susceptibility to contamination. Contemporary gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry permit sensitive measurement when extraction, calibration, identity criteria, and matrix-specific validation are adequate. The review emphasises that biomarker concentrations cannot independently determine product identity, intent, dependence, impairment, fatal dose, or cause of death. Robust interpretation requires a documented specimen, appropriate analytical quality assurance, an explicit account of competing explanations, and integration with independent clinical and circumstantial evidence. The clinical and forensic utility of multi-analyte strategies is greatest when each component addresses a distinct and supportable inferential question.

Authors

Institutions

Publication Details

Journal
Journal of Disease and Global Health
Published
2026-11-16
DOI
https://doi.org/10.56557/jodagh/2026/v19i211376
Primary Topic
Forensic Toxicology and Drug Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biomarkers of Nicotine Exposure: Forensic Toxicological Significance, Analytical Methods, and Interpretative Challenges

Chanchal Kumar, Megha Yadav, Blessi N. Uikey, Kalyani Kumari et al.
Journal of Disease and Global Health
Forensic Toxicology and Drug Analysis
article

Biomarkers of Nicotine Exposure: Forensic Toxicological Significance, Analytical Methods, and Interpretative Challenges

Chanchal Kumar, Megha Yadav, Blessi N. Uikey, Kalyani Kumari, Shantnu Singh Rathore
article en

Abstract

Nicotine exposure may arise from combustible tobacco, smokeless tobacco, electronic nicotine delivery systems, heated tobacco products, nicotine replacement medicines, occupational contact, environmental contamination, or accidental and intentional ingestion. A forensic measurement must therefore address a specific question rather than simply establish whether a nicotine-related compound is present. This narrative review examines nicotine pharmacokinetics, major biomarkers, biological specimens, analytical methods, and the evidentiary boundaries of interpretation. Parent nicotine is most informative about relatively recent exposure but is rapidly redistributed and eliminated. Cotinine offers a longer detection interval, whereas trans-3′-hydroxycotinine and the nicotine metabolite ratio inform metabolic activity. Urinary total nicotine equivalents can characterise nicotine intake more comprehensively in research settings. The tobacco-specific nitrosamine metabolite NNAL provides evidence of exposure to the tobacco-derived precursor NNK over a comparatively prolonged period, although it does not measure nicotine dose or establish a precise exposure date. Blood, urine, saliva, hair, and nails differ in sampling practicality, analyte concentration, temporal resolution, and susceptibility to contamination. Contemporary gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry permit sensitive measurement when extraction, calibration, identity criteria, and matrix-specific validation are adequate. The review emphasises that biomarker concentrations cannot independently determine product identity, intent, dependence, impairment, fatal dose, or cause of death. Robust interpretation requires a documented specimen, appropriate analytical quality assurance, an explicit account of competing explanations, and integration with independent clinical and circumstantial evidence. The clinical and forensic utility of multi-analyte strategies is greatest when each component addresses a distinct and supportable inferential question.

Journal of Disease and Global HealthVol. 19(2)
Guru Ghasidas Vishwavidyalaya (IN), Kalinga University (IN), Mandsaur University (IN)
Good health and well-being
Forensic Toxicology and Drug Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon